ArticleJournal of experimental & clinical cancer research : CR2019

Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4.

Meng-Xuan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.